Other markers such as fibroblast-specific protein 1 (FSP1), neuron-glial antigen 2 (NG2), and prolyl 4-hydroxylase can be useful to identify CAFs subtypes in carcinomas [6]. Here, S100A4 is linked to carcinoma.